Edition:
United States

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

24.22EUR
15 Dec 2017
Change (% chg)

€-0.10 (-0.43%)
Prev Close
€24.32
Open
€24.23
Day's High
€24.35
Day's Low
€24.06
Volume
1,001,354
Avg. Vol
570,694
52-wk High
€27.73
52-wk Low
€17.38

Latest Key Developments (Source: Significant Developments)

Grifols says FDA approves genetic test and EMA biological sealant
Friday, 17 Nov 2017 11:32am EST 

Nov 17 (Reuters) - GRIFOLS SA ::GETS APPROVAL FROM US FOOD AND DRUG ADMINISTRATION (FDA) FOR ITS NEW GENETIC TEST TO DETECT ALPHA-1 ANTITRYPSIN DEFICIENCY‍​.THE EUROPEAN MEDICINES AGENCY (EMA) APPROVES NEW PRODUCT, BIOLOGICAL SEALANT, TO USE IN SURGICAL OPERATIONS IN ADULTS.‍​.  Full Article

Grifols gets approval from US FDA for new product
Monday, 6 Nov 2017 02:25am EST 

Nov 6 (Reuters) - GRIFOLS SA ::EARNS APPROVAL FROM US FOOD AND DRUG ADMINISTRATION (FDA) FOR NEW PRODUCT FIBRIN SEALANT (HUMAN) COMPOSED OF TWO PLASMA PROTEINS AND INDICATED FOR SURGICAL USE IN ADULTS.‍​.  Full Article

Grifols 9-month net profit up 6.3 pct at 431.8 mln euros YoY
Thursday, 2 Nov 2017 03:22am EDT 

Nov 2 (Reuters) - GRIFOLS SA ::9-MONTH NET PROFIT 431.8 MILLION EUROS VERSUS 406.1 MILLION EUROS YEAR AGO.9-MONTH NET SALES 3.25 BILLION EUROS VERSUS 2.95 BILLION EUROS YEAR AGO.9-MONTH EBITDA 960.9 MILLION EUROS VERSUS 842.9 MILLION EUROS YEAR AGO.  Full Article

Grifols approves interim dividend of 0.18 eur/shr
Monday, 30 Oct 2017 03:18am EDT 

Oct 30 (Reuters) - GRIFOLS SA ::APPROVES INTERIM DIVIDEND OF 0.18 EURO PER SHARE PAYABLE DECEMBER 5‍​.  Full Article

Grifols gets FDA approval for Prolastin-C
Friday, 22 Sep 2017 02:27am EDT 

Sept 22 (Reuters) - GRIFOLS SA ::SAYS GETS APPROVAL FROM FDA (US FOOD AND DRUG ADMINISTRATION) FOR PROLASTIN-C LIQUID AS A REPLACEMENT THERAPY‍​ TO TREAT RARE GENETIC DISORDER.SAYS COMMERCIAL LAUNCH OF LIQUID FORMULATION PROLASTIN-C IS SCHEDULED FOR 2018.THE APPROVAL PROCESS FOR THE PRODUCT ALSO COMMENCED IN EUROPE.  Full Article

Grifols H1 EBITDA up 16.4 pct versus last year
Friday, 28 Jul 2017 02:32am EDT 

July 28 (Reuters) - GRIFOLS SA ::H1 NET PROFIT 277.9 MILLION EUROS VERSUS 264.4 MILLION EUROS YEAR AGO.H1 EBITDA 644.4 MILLION EUROS VERSUS 553.6 MILLION EUROS YEAR AGO.H1 NET REVENUE 2.19 BILLION EUROS VERSUS 1.95 BILLION EUROS YEAR AGO.H1 NET INVESTMENT IN R+D UP 19 PERCENT AT 129.3 MILLION EUROS.  Full Article

Grifols reaches 90 pct stake in Kiro Grifols
Tuesday, 25 Jul 2017 02:30am EDT 

July 25 (Reuters) - GRIFOLS ::SAYS BUYS ADDITIONAL 40 PERCENT OF KIRO GRIFOLS SL FOR 12.8 MILLION EUROS‍​.SAYS AFTER THE TRANSACTION REACHES 90 PERCENT STAKE IN KIRO GRIFOLS.THE REMAINING 10 PERCENT OF KIRO GRIFOLS WILL CONTINUE TO BE HELD BY SOCIOS FUNDADORES KIRO SL.  Full Article

Grifols buys 44 pct stake in GigaGen for $35 mln
Wednesday, 5 Jul 2017 02:37am EDT 

July 5 (Reuters) - GRIFOLS SA ::SAYS BUYS 43.96 PERCENT SHAREHOLDING IN GIGAGEN INC FOR $35 MILLION.SAYS GIGAGEN TO CARRY OUT RESEARCH FOR GRIFOLS FOR A FEE OF $15 MILLION IN THERAPIES DERIVED FROM HUMAN B-CELLS.  Full Article

Grifols' unit to initiate phase II clinical trials of Alzheimer's vaccine
Tuesday, 27 Jun 2017 05:33am EDT 

June 27 (Reuters) - GRIFOLS SA ::SAYS ITS UNIT ARACLON BIOTECH RECEIVES APPROVAL TO INITIATE PHASE II CLINICAL TRIALS OF ITS ALZHEIMER'S VACCINE.  Full Article

Grifols enters into exclusive long-term distribution deal with Beckman Coulter
Monday, 12 Jun 2017 04:00am EDT 

June 12 (Reuters) - Grifols SA ::SAYS ENTERS INTO AN EXCLUSIVE LONG TERM DISTRIBUTION AGREEMENT WITH BECKMAN COULTER.  Full Article

BRIEF-Grifols Gets Loan With EIB For 85 Mln Euros

* GETS LONG-TERM LOAN WITH THE EUROPEAN INVESTMENT BANK (EIB) FOR 85 MILLION EUROS